Regeneron Pharmaceuticals Inc · Healthcare
Regeneron Pharmaceuticals Inc (REGN) is a stock traded in US markets in the Healthcare sector. P/E 19.48, P/B 2.57, ROE 14.04% and dividend yield 0.44%. The P/E multiple helps compare this asset's valuation with other companies in the same sector. Explore the public market data tracked by FundamentalRadar. This page includes key fundamental indicators, recent distributions and financial statements available from the public sources tracked by FundamentalRadar.
The source returned no recent distributions for this asset.
Financial statements are not available for this asset yet.
The current price of REGN is $788.04.
The P/E ratio of REGN is 19.48, meaning investors pay 19.48 times earnings per share.
The P/B of REGN is 2.57, meaning the stock trades at 2.57 times its book value per share.
The ROE (Return on Equity) of REGN is 14.04%, meaning the company generates 14.04% of profit for every unit of shareholders' equity.
The dividend yield of REGN is 0.44%. This represents the annual dividend relative to the current share price.
The market capitalization of REGN is US$ 81.1 B.
The net profit margin of REGN is 27.86%, meaning the company keeps 27.86% of revenue as profit.
The debt-to-equity ratio of REGN is 0.09, meaning the company has 0.09 units of debt for each unit of equity.
REGN operates in the Healthcare sector.